About the AuthorMy name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
My ProfileI am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!
About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Legislative Tracking Tools
Monthly Archives: September 2010
The U.S. Pharmacopeia – What is it? What Does it Do?
One of the most frequent searches I see that people perform when coming to Eye on FDA is this – "Are Canadian Drugs Safe"? And safety, in this day and age, is the name of the game. As I've … Continue reading
Weekly Roundup – 09/17/10
Well…. Congress is back. Nuff said on that. The rest of us are changing gears to autumn. The summer linens and whites are now stored away in my summer closet. The white bucks have been put away. I'm looking … Continue reading
Posted in Uncategorized Comments Off on Weekly Roundup – 09/17/10
Lilly Jumps in the Social Media Pool
Forgive all the font craziness here – my blogging platform went a little crazy. Yesterday morning I was on the i-Pad early and was going through my emails and there was a notification that someone called @Lillypad had started … Continue reading
Posted in Uncategorized 3 Comments
How Might Mid-term Elections Impact FDA and Pharma?
Yesterday the Senate returned to Washington after recess and today the House returns. Yes, they're baaaaack. That means traffic and congestion has increased and a tidy 12 minute commute turns into a 45 minute snarl. Consider that a metaphor. Today … Continue reading
Posted in Uncategorized Comments Off on How Might Mid-term Elections Impact FDA and Pharma?
Weekly Roundup – 09/10/10
For a short week, it seemed like a long one. And you can tell by my few posts this week, it was a busy one. Here in Washington, we immediately turned a climate corner with the Labor Day holiday and … Continue reading
Posted in Weekly Roundup Comments Off on Weekly Roundup – 09/10/10